These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 24613272)
1. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings. Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272 [TBL] [Abstract][Full Text] [Related]
2. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China. Chen N; Jin K; Xu J; Zhang J; Weng Y Int J Infect Dis; 2019 Feb; 79():34-36. PubMed ID: 30423460 [TBL] [Abstract][Full Text] [Related]
3. [Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging]. Bédat-Millet AL; Charpentier S; Monge-Strauss MF; Woimant F Rev Neurol (Paris); 2000 May; 156(5):505-9. PubMed ID: 10844370 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature. Kager PA; Schipper HG; Stam J; Majoie CB Am J Trop Med Hyg; 2009 Jun; 80(6):947-52. PubMed ID: 19478256 [TBL] [Abstract][Full Text] [Related]
6. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease. Truc P; Lando A; Penchenier L; Vatunga G; Josenando T Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811 [TBL] [Abstract][Full Text] [Related]
8. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225 [TBL] [Abstract][Full Text] [Related]
9. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Kennedy PG Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189 [TBL] [Abstract][Full Text] [Related]
10. [Congenital human African trypanosomiasis: an observation at the University Hospital of Brazzaville (Congo)]. Oba A; Gahtse A; Ekouya Bowassa G; Nika E; Obengui Arch Pediatr; 2011 Oct; 18(10):1114-5. PubMed ID: 21873039 [No Abstract] [Full Text] [Related]
11. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers. Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219 [TBL] [Abstract][Full Text] [Related]
12. The continuing problem of human African trypanosomiasis (sleeping sickness). Kennedy PG Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506 [TBL] [Abstract][Full Text] [Related]
13. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis. Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605 [TBL] [Abstract][Full Text] [Related]
15. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness. Khonde N; Pépin J; Mpia B Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773 [TBL] [Abstract][Full Text] [Related]
16. [Sleeping sickness as an import pathology following a stay in Zaire]. Buyse D; Van den Ende J; Vervoort T; Van den Enden E Acta Clin Belg; 1996; 51(6):409-11. PubMed ID: 9027191 [TBL] [Abstract][Full Text] [Related]
17. Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis. Mumba Ngoyi D; Lejon V; N'Siesi FX; Boelaert M; Büscher P Trop Med Int Health; 2009 Apr; 14(4):438-44. PubMed ID: 19228348 [TBL] [Abstract][Full Text] [Related]